Vaccine Analysis for a New Era
As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing
False
As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing
The analytical demands for vaccines now include potency, structure, and biological activity, beyond just measuring antigen levels.
David Hage's research focuses on high-performance immunoaffinity chromatography to improve vaccine analysis efficiency and automation.
New vaccines require rapid and convenient methods for assessing their biological and immunological activity, highlighting the need for advanced analytical techniques.
High-performance immunoaffinity chromatography offers faster assays with high precision and reusability compared to traditional immunoassay methods.
The development of new analytical methods will continue to evolve as vaccine technology advances, addressing the need for detailed structural and activity information.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

False
False
December 18, 2024
4 min read
Konstantin Shoykhet, Agilent, talks about exciting developments in liquid chromatography, big challenges, and instrument accessibility
December 19, 2024
4 min read
What are the most exciting developments and emerging trends in analytical science today? We asked the 2024 Power List
December 20, 2024
2 min read
2024’s technological standouts, a new way of pinpointing painkillers, and needles made from bone…
Affiliations:
Specialties:
Areas of Expertise:
False